FIJYX Mutual Fund (Fidelity Advisor Biotechnology Fund Class Z) is managed by Fidelity Investments (US) with $151.6M in net assets. FIJYX expense ratio is 0.58%, holding 92 positions across sectors including Health Care, Financials, Unknown. Inception date: 2018-10-02.

FIJYX performance shows a YTD return of 5.85%. The 1-year return is 58.25% and the 5-year return is 10.64%. FIJYX dividend yield stands at 1.14%, paid annually.

FIJYX top holdings include Abbvie Inc (16.6%), Gilead Sciences Inc (6.6%), Alnylam Pharmace (5.0%), Ascendis Pharma As Adr (4.5%), Cogent Biosciences Inc (3.8%). View all FIJYX holdings, sector breakdown, or dividend history.

FIJYX can be compared against other funds using the overlap calculator or side-by-side comparison tool. FIJYX alternatives are available via the screener, along with tax-loss harvesting opportunities.